TY - JOUR
T1 - Progressive cavitating leukoencephalopathy
T2 - A novel childhood disease
AU - Naidu, Sakkubai
AU - Bibat, Genila
AU - Lin, Doris
AU - Burger, Peter
AU - Barker, Peter
AU - Rosemberg, Sergio
AU - Braverman, Nancy
AU - Arroyo, Hugo
AU - Dowling, Michael
AU - Hamosh, Ada
AU - Kimonis, Virginia
AU - Blank, Carol
AU - Fiumara, Agata
AU - Facchini, Sergio
AU - Singhal, Bhim
AU - Moser, Hugo
AU - Kelley, Richard
AU - DiMauro, Salvatore
PY - 2005/12
Y1 - 2005/12
N2 - We report 19 patients with a previously undelineated neurodegenerative syndrome characterized by episodic acute onset of irritability or neurological deficits between 2 months and 3.5 years of age, followed by steady or intermittent clinical deterioration. Seven children died between 11 months and 14 years of age. Cranial magnetic resonance imaging (MRI) shows patchy leukoencephalopathy with cavities, and vascular permeability, in actively affected regions. Early lesions affect corpus callosum and centrum semiovale, with or without cerebellar or cord involvement. After repeated episodes, areas of tissue loss coalesce with older lesions to become larger cystic regions in brain or spinal cord. Diffuse spasticity, dementia, vegetative state, or death ensues. Gray matter is spared until late in the course. In some, incomplete clinical or MRI recovery occurs after episodes. The clinical course varies from rapid deterioration to prolonged periods of stability that are unpredictable by clinical or MRI changes. Elevated levels of lactate in brain, blood, and cerebrospinal fluid, abnormal urine organic acids, and changes in muscle respiratory chain enzymes are present but inconsistent, without identifiable mitochondrial DNA mutations or deletions. Pathological studies show severe loss of myelin sparing U-fibers, axonal disruption, and cavitary lesions without inflammation. Familial occurrence and consanguinity suggest autosomal recessive inheritance of this distinct entity.
AB - We report 19 patients with a previously undelineated neurodegenerative syndrome characterized by episodic acute onset of irritability or neurological deficits between 2 months and 3.5 years of age, followed by steady or intermittent clinical deterioration. Seven children died between 11 months and 14 years of age. Cranial magnetic resonance imaging (MRI) shows patchy leukoencephalopathy with cavities, and vascular permeability, in actively affected regions. Early lesions affect corpus callosum and centrum semiovale, with or without cerebellar or cord involvement. After repeated episodes, areas of tissue loss coalesce with older lesions to become larger cystic regions in brain or spinal cord. Diffuse spasticity, dementia, vegetative state, or death ensues. Gray matter is spared until late in the course. In some, incomplete clinical or MRI recovery occurs after episodes. The clinical course varies from rapid deterioration to prolonged periods of stability that are unpredictable by clinical or MRI changes. Elevated levels of lactate in brain, blood, and cerebrospinal fluid, abnormal urine organic acids, and changes in muscle respiratory chain enzymes are present but inconsistent, without identifiable mitochondrial DNA mutations or deletions. Pathological studies show severe loss of myelin sparing U-fibers, axonal disruption, and cavitary lesions without inflammation. Familial occurrence and consanguinity suggest autosomal recessive inheritance of this distinct entity.
UR - http://www.scopus.com/inward/record.url?scp=28544444511&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=28544444511&partnerID=8YFLogxK
U2 - 10.1002/ana.20671
DO - 10.1002/ana.20671
M3 - Article
C2 - 16315274
AN - SCOPUS:28544444511
SN - 0364-5134
VL - 58
SP - 929
EP - 938
JO - Annals of neurology
JF - Annals of neurology
IS - 6
ER -